Tudor Financial Inc. Purchases 165 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Tudor Financial Inc. lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.9% in the fourth quarter, HoldingsChannel reports. The fund owned 2,947 shares of the financial services provider’s stock after buying an additional 165 shares during the period. Tudor Financial Inc.’s holdings in iShares Biotechnology ETF were worth $390,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in IBB. Ameritas Advisory Services LLC increased its holdings in iShares Biotechnology ETF by 9.4% in the fourth quarter. Ameritas Advisory Services LLC now owns 29,094 shares of the financial services provider’s stock valued at $3,847,000 after purchasing an additional 2,508 shares during the last quarter. Mirador Capital Partners LP increased its holdings in iShares Biotechnology ETF by 0.6% in the fourth quarter. Mirador Capital Partners LP now owns 29,698 shares of the financial services provider’s stock valued at $3,926,000 after purchasing an additional 187 shares during the last quarter. Clarus Wealth Advisors increased its holdings in iShares Biotechnology ETF by 1.4% in the fourth quarter. Clarus Wealth Advisors now owns 11,383 shares of the financial services provider’s stock valued at $1,526,000 after purchasing an additional 161 shares during the last quarter. Pines Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at about $317,000. Finally, Sharper & Granite LLC increased its holdings in iShares Biotechnology ETF by 2.8% in the fourth quarter. Sharper & Granite LLC now owns 6,250 shares of the financial services provider’s stock valued at $826,000 after purchasing an additional 170 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.2 %

NASDAQ IBB opened at $132.65 on Tuesday. The stock has a 50-day simple moving average of $136.32 and a 200 day simple moving average of $141.84. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.